• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

Comprehensive Overview of 7-(Trifluoromethyl)quinolin-3-amine (CAS No. 1402576-61-7): Properties, Applications, and Research Insights

7-(Trifluoromethyl)quinolin-3-amine (CAS No. 1402576-61-7) is a specialized quinoline derivative that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. The compound's trifluoromethyl group enhances its lipophilicity and metabolic stability, making it a valuable building block in drug discovery. Researchers are increasingly exploring its potential in kinase inhibition and antimicrobial applications, aligning with current trends in precision medicine and antibiotic resistance solutions.

The growing demand for fluorinated compounds in medicinal chemistry has propelled interest in CAS No. 1402576-61-7. Its molecular structure combines the quinoline scaffold—known for diverse biological activities—with the strategic CF3 substitution at the 7-position, which improves binding affinity to biological targets. Recent studies highlight its relevance in developing next-generation therapeutics for inflammatory diseases and cancer immunotherapy, addressing key healthcare challenges highlighted in WHO reports and NIH roadmaps.

From a synthetic chemistry perspective, 7-(Trifluoromethyl)quinolin-3-amine serves as a versatile intermediate for constructing heterocyclic frameworks. Its nucleophilic amine group at the 3-position allows for diverse functionalization, enabling the creation of structure-activity relationship (SAR) libraries. This aligns with the pharmaceutical industry's focus on fragment-based drug design and high-throughput screening methodologies, which dominate current PubMed and ACS journal publications.

Environmental and regulatory aspects of CAS 1402576-61-7 are also under scrutiny, particularly regarding green chemistry principles. The compound's fluorine content raises questions about persistence in ecosystems, mirroring broader concerns about PFAS alternatives discussed at recent ACS Green Chemistry Institute conferences. However, its relatively low ecotoxicity profile compared to heavier halogens positions it as a potential sustainable fluorochemical candidate.

Analytical characterization of 7-(Trifluoromethyl)quinolin-3-amine typically involves advanced techniques like LC-MS and NMR spectroscopy, with particular attention to the 19F-NMR signal pattern. These methods are crucial for quality control in GMP-compliant synthesis, especially given the compound's increasing use in API development. The HPLC purity standards for this material often exceed 98%, reflecting its importance in preclinical research pipelines.

Market intelligence indicates rising procurement of CAS 1402576-61-7 by CROs and biotech startups focused on targeted protein degradation platforms. This correlates with the explosive growth of PROTAC technology searches in SciFinder and Reaxys databases. The compound's ability to serve as a ligand precursor for E3 ubiquitin ligase recruitment makes it particularly valuable in this cutting-edge therapeutic modality.

In material science applications, the electron-withdrawing trifluoromethyl group of this quinoline derivative contributes to interesting photophysical properties. Researchers are investigating its potential in organic electronics, particularly as a charge transport modifier in OLED materials—a hot topic in ACS Materials Letters and Advanced Functional Materials journals. This dual applicability in life sciences and advanced materials underscores the compound's interdisciplinary significance.

Safety assessments of 7-(Trifluoromethyl)quinolin-3-amine emphasize proper handling under standard laboratory protocols, with particular attention to amine reactivity. While not classified as hazardous under GHS criteria, material safety data sheets recommend engineering controls during large-scale processing—a consideration increasingly important for CDMOs scaling up production to meet clinical trial demands.

The patent landscape surrounding CAS 1402576-61-7 reveals strategic filings by major pharma companies, particularly in JAK-STAT pathway inhibitors and TLR modulators. This intellectual property activity reflects the compound's value in immuno-oncology—one of the most funded therapeutic areas according to BioWorld market reports. Academic technology transfer offices are also actively licensing synthetic methodologies involving this fluorinated building block.

Future research directions for 7-(Trifluoromethyl)quinolin-3-amine likely include continuous flow synthesis optimization and biocatalytic approaches to introduce the trifluoromethyl group—both trending topics in process chemistry circles. The compound's role in AI-assisted drug discovery platforms also warrants exploration, given the pharmaceutical industry's investment in machine learning for molecular design.

• 243666-11-7(4-Amino-7-(trifluoromethyl)quinoline)
• 347146-22-9(8-(trifluoromethyl)quinolin-3-amine)
• 247113-89-9(4-Amino-6-(trifluoromethyl)quinoline)
• 872604-29-0(9H-Carbazol-3-amine, 7-(trifluoromethyl)-)
• 872604-26-7(9H-Carbazol-3-amine, 6-(trifluoromethyl)-)
• 1447606-61-2(5-(trifluoromethyl)quinolin-7-amine)
• 872604-18-7(9H-Carbazol-2-amine, 6-(trifluoromethyl)-)
• 872604-14-3(9H-Carbazol-2-amine, 7-(trifluoromethyl)-)
• 1082750-49-9(6-(trifluoromethyl)quinolin-3-amine)
• 321-71-1(7-(trifluoromethyl)quinolin-5-amine)